吸入麻醉劑市場：按產品、應用、最終用戶和地區分類

Inhalation Anesthesia Market, By Product, By Application, By End Users, and By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，吸入麻醉劑市場規模將達到 15.652 億美元，到 2033 年將達到 22.769 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 5.5%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	15.652億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.50%	2033年市場規模預測：	22.769億美元

吸入麻醉劑（例如氧化亞氮、氟烷、Isoflurane、DESFLURANE和SEVOFLURANE，這些是目前臨床上最常用的藥物）用於手術室中全身麻醉的誘導和維持。吸入麻醉劑是維持麻醉的首選，因為它們可以更精確地控制麻醉狀態，而且給藥成本更低。

市場動態

例如，2022年8月，領先的綜合醫院學名藥供應商Piramal Pharma Limited的重症加護業務部門宣佈在美國推出首個上市的學名藥硫酸鋅注射液。該產品已獲得美國食品藥物管理局（FDA）的核准，核准途徑為競爭性非專利藥療法（CGT），旨在促進壟斷性藥品供應商之間的市場競爭。此注射液有30毫克/10毫升（3毫克/毫升）和25毫克/5毫升（5毫克/毫升）兩種規格。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數，對全球吸入麻醉劑市場的主要參與者進行了分析。
本報告中的見解將使企業負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球吸入麻醉劑市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球吸入麻醉劑市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 1,565.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.50%	2033 Value Projection:	USD 2,276.9 Mn

Inhalation anesthetics (such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane; most commonly used agents in practice today) are used for induction and maintenance of general anesthesia in the operating room. Inhaled anesthetics are preferred for maintenance of anesthesia because they allow a more precise control of the anesthetic state and do so at low cost.

Market Dynamics

For instance, in August 2022, Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announced the First to Market Generic U.S. launch of the Zinc Sulfate Injection. This product is U.S. Food and Drug Administration approved with Competitive Generic Therapy (CGT) designation; an approval pathway intended to enhance market competition for sole source drugs. The injection is available in 30mg/10mL (3mg/mL) and 25mg/5mL (5mg/mL).

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global inhalation anesthesia market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbvie Inc., Novartis AG, Piramal Enterprises Ltd., Hikma Pharmaceuticals Plc, Fresenius SE & CO. KGaA, Halocarbon Products Corporation, Baxter International Inc., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global inhalation anesthesia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthesia market.

Market Segmentation

Global Inhalation Anesthesia Market, By Product (Revenue, USD Mn, 2021 - 2033)
Sevoflurane
Desflurane
Isoflurane
Nitrous Oxide
Global Inhalation Anesthesia Market, By Application (Revenue, USD Mn, 2021 - 2033)
Induction
Maintenance
Global Inhalation Anesthesia Market, By End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Global Inhalation Anesthesia Market, By Geography (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Abbvie Inc.
Novartis AG
Piramal Enterprises Ltd.
Hikma Pharmaceuticals Plc
Fresenius SE & CO. KgaA
Baxter International Inc.
Troikaa Pharmaceuticals, Ltd.
Halocarbon Products Corporation
Jiangsu Hengrui Medicine Co., Ltd.
Lunan Pharmaceutical Group Co. Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- High burden of chronic disease and growing geriatric population
- Side-effects and rise in demand or adoption of generic drugs
- Increasing demand or use of novel inhalation anesthetic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Inhalation Anesthesia Market, By Product, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Sevoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Nitrous Oxide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global Inhalation Anesthesia Market, By Application, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Inhalation Anesthesia Market, By End User, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global Inhalation Anesthesia Market, By Geography, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)

8. Competitive Landscape

Abbvie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Piramal Enterprises Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius SE & CO. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Troikaa Pharmaceuticals, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Halocarbon Products Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jiangsu Hengrui Medicine Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lunan Pharmaceutical Group Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views